Catheter Precision Inc (VTAK)
0.426
+0.01
(+1.43%)
USD |
NYAM |
Nov 21, 16:00
0.415
-0.01
(-2.58%)
After-Hours: 20:00
Catheter Precision Profit Margin (Quarterly): -4.29K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -4.29K% |
June 30, 2024 | -4.54K% |
March 31, 2024 | -3.26K% |
December 31, 2023 | -522.7% |
September 30, 2023 | -1.45K% |
June 30, 2023 | -1.64K% |
March 31, 2023 | -78.12K% |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | -169.0K% |
March 31, 2022 | -61.06K% |
December 31, 2021 | -165.7K% |
September 30, 2021 | -85.96K% |
June 30, 2021 | -58.32K% |
March 31, 2021 | -180.9K% |
December 31, 2020 |
Date | Value |
---|---|
September 30, 2020 | -11.44K% |
June 30, 2020 | -1.12K% |
March 31, 2020 | -560.5% |
December 31, 2019 | -700.9% |
September 30, 2019 | -912.9% |
June 30, 2019 | -702.4% |
March 31, 2019 | -839.5% |
December 31, 2018 | -751.4% |
September 30, 2018 | -232.9% |
June 30, 2018 | -679.2% |
March 31, 2018 | -277.9% |
December 31, 2017 | -159.8% |
September 30, 2017 | -133.2% |
June 30, 2017 | -715.1% |
March 31, 2017 | -156.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-180.9K%
Minimum
Mar 2021
-522.7%
Maximum
Dec 2023
-48.74K%
Average
-4.54K%
Median
Jun 2024
Profit Margin (Quarterly) Benchmarks
Plus Therapeutics Inc | -- |
Perspective Therapeutics Inc | -- |
Retractable Technologies Inc | -18.58% |
InfuSystems Holdings Inc | 5.12% |
Xtant Medical Holdings Inc | -17.98% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -65.84% |
Return on Assets | -40.39% |
Return on Invested Capital | -63.93% |
Gross Profit Margin (Quarterly) | 89.58% |
Operating Margin (Quarterly) | -2.98K% |
Return on Net Operating Assets | -44.59% |